Welcome to
Sysmex Flow Cytometry Belgium!

For ordering please make sure you are in your local shop.
If you are from Belgium then please continue.
Otherwise please go to your country.

Go to my country Continue

CyFlow™ CD27 Purified

CyFlow™ CD27 Purified
Antigen: CD27
Alternative Name: S152, T14, TNFRSF7, TP55
Clone: LT27
Application: Flow cytometry
Format/Fluorochrome: Purified
Target Species: Human
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Isotype: IgG2a
Order number: CY176848

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

HLDA Workshop HLDA V—WS Code T T-CD27.01 Concentration Unit mg/mL Concentration 1... more
CyFlow™ CD27 Purified
HLDA WorkshopHLDA V—WS Code T T-CD27.01
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1
ImmunogenHuman peripheral blood lymphocytes
Background InformationCD27 is a transmembrane 55 kDa protein of the nerve growth factor-receptor family, expressed as a disulfide-linked homodimer on mature thymocytes, peripheral blood T cells and a subpopulation of B cells. Activation of T cells via TCR-CD3 complex results in upregulation of CD27 expression on the plasma membrane as well as in the release of its soluble 28-32 kDa form, sCD27, detected in the plasma, urine or spinal fluid. This sCD27 is an important prognostic marker of acute and chronic B cell malignancies. RgpA, a cystein proteinase, although activating T cells through the protease-activated receptors (PARs), degradates CD27 and counteracts T cell activation mediated by CD27 and its ligand CD70.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Doussis IA, Gatter KC, Mason DY: CD68 reactivity of non‑macrophage derived tumours in cytological specimens. J·Clin·Pathol. 1993·Apr; 46(4):334‑6. <·PMID:·7684403·> | van Oers MH, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer JM, Hintzen RQ, von dem Borne AE, van Lier RA: Expression and release of CD27 in human B‑cell malignancies. Blood. 1993·Dec·1; 82(11):3430‑6. <·PMID:·8241510·> | Molica S, Vitelli G, Levato D, Crispino G, Dell'Olio M, Dattilo A, Matera R, Gandolfo GM, Musto P: CD27 in B‑cell chronic lymphocytic leukemia: Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily. Haematologica. 1998·May; 83(5):398‑402l. <·PMID:·9658722·> | Kara IO, Sahin B, Gunesacar R: Expression of soluble CD27 and interleukins‑8 and ‑10 in B‑cell chronic lymphocytic leukemia: correlation with disease stage and prognosis. Adv·Ther. 2007·Jan-Feb; 24(1):29‑40. <·PMID:·17526459·> | Yun LW, Decarlo AA, Hunter N: Blockade of protease‑activated receptors on T cells correlates with alterd proteolysis of CD27 by gingipains of Porphyromonas gingivalis. Clin·Exp·Immunol. 2007·Nov; 150(2):217‑29. <·PMID:·17937677·> | Kanderova V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, Hrusak O, Lund‐Johansen F, Kalina T: High‐resolution antibody array analysis of childhood acute leukemia cells. Mol·Cell·Proteomics. 2016·Apr·1; 15(4):1246‐61. <·PMID:·26785729·>

Article successfully added.